巨星医疗控股(02393.HK)中期收益减少约37.0%至8.03亿元

Core Viewpoint - The company, Giant Star Medical Holdings, reported a significant decline in overall revenue and gross profit due to the impact of China's centralized procurement policy on its main revenue source, the medical segment [1] Financial Performance - Total revenue for the six months ending June 30, 2025, decreased by approximately 37.0% year-on-year to RMB 802.6 million [1] - Gross profit fell by about 38.6% year-on-year to RMB 133.7 million [1] - The profit for the period was RMB 11.15 million, a sharp decline from RMB 1.09 billion in the same period last year [1]